Cargando…
Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647882/ https://www.ncbi.nlm.nih.gov/pubmed/34881357 http://dx.doi.org/10.1097/HS9.0000000000000655 |
| _version_ | 1784610687943704576 |
|---|---|
| author | Vercueil, Colin Eberst, Lauriane Humbrecht, Catherine Fornecker, Luc-Matthieu |
| author_facet | Vercueil, Colin Eberst, Lauriane Humbrecht, Catherine Fornecker, Luc-Matthieu |
| author_sort | Vercueil, Colin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8647882 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86478822021-12-07 Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia Vercueil, Colin Eberst, Lauriane Humbrecht, Catherine Fornecker, Luc-Matthieu Hemasphere Case Report Lippincott Williams & Wilkins 2021-11-12 /pmc/articles/PMC8647882/ /pubmed/34881357 http://dx.doi.org/10.1097/HS9.0000000000000655 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Case Report Vercueil, Colin Eberst, Lauriane Humbrecht, Catherine Fornecker, Luc-Matthieu Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia |
| title | Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia |
| title_full | Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia |
| title_fullStr | Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia |
| title_full_unstemmed | Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia |
| title_short | Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia |
| title_sort | efficacy of serotherapy on an n501y variant of sars-cov-2 in a patient with chronic lymphocytic leukemia |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647882/ https://www.ncbi.nlm.nih.gov/pubmed/34881357 http://dx.doi.org/10.1097/HS9.0000000000000655 |
| work_keys_str_mv | AT vercueilcolin efficacyofserotherapyonann501yvariantofsarscov2inapatientwithchroniclymphocyticleukemia AT eberstlauriane efficacyofserotherapyonann501yvariantofsarscov2inapatientwithchroniclymphocyticleukemia AT humbrechtcatherine efficacyofserotherapyonann501yvariantofsarscov2inapatientwithchroniclymphocyticleukemia AT forneckerlucmatthieu efficacyofserotherapyonann501yvariantofsarscov2inapatientwithchroniclymphocyticleukemia |